About Immune
Immune is a private company based in Boston, Massachusetts, incorporated in 2023 in Delaware. It has reported $7,399,986 raised in two offerings on Form D since February 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | Feb 3, 2025 | $6,399,986of $7.0M target | 13 | $492K | EquityRule 506(b) | Form D ↗ |
| Jan 27, 2025 | Feb 3, 2025 | $1,000,000fully sold | 6 | $166K | Equity, Simple Agreement for Future Equity (SAFEs)Rule 506(b) | Form D ↗ |
| Total, two offerings | $7,399,986 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Immune's Form D filed Feb 3, 2025.
AT
Ariana Thacker
President